1-(5-isoquinolinesulfonyl)-2-methylpiperazine has been researched along with monorden in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fujishima, H; Kohno, K; Masumoto, N; Nakano, S; Niho, Y | 1 |
1 other study(ies) available for 1-(5-isoquinolinesulfonyl)-2-methylpiperazine and monorden
Article | Year |
---|---|
v-src induces cisplatin resistance by increasing the repair of cisplatin-DNA interstrand cross-links in human gallbladder adenocarcinoma cells.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Adenocarcinoma; Androstadienes; Benzoquinones; Cell Survival; Cisplatin; DNA Adducts; DNA Damage; DNA Repair; Drug Resistance, Neoplasm; Enzyme Inhibitors; Gallbladder Neoplasms; Genes, src; Humans; Lactams, Macrocyclic; Lactones; Macrolides; Oncogene Protein pp60(v-src); Phosphoinositide-3 Kinase Inhibitors; Protein-Tyrosine Kinases; Quinones; Recombinant Proteins; Rifabutin; Transfection; Tumor Cells, Cultured; Wortmannin | 1999 |